Aion Therapeutic Inc. (ANTCF)

USD 0.0

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 367.47 Thousand - - - - -
Cost of Revenue 204.36 Thousand 17.3 Thousand 65.29 Thousand 128.13 Thousand 111.05 Thousand -
Gross Profit 163.11 Thousand -17.3 Thousand -65.29 Thousand -128.13 Thousand -111.05 Thousand -
Operating Expenses 163.11 Thousand 842.33 Thousand 2.81 Million 2.78 Million 982.64 Thousand 1.7 Million
Selling, General and Administrative Expenses 1.02 Million 842.33 Thousand 1.13 Million 2.16 Million 579.12 Thousand 1.03 Million
Research and Development Expenses - - 953 Thousand - 18.4 Thousand 15.99 Thousand
Other Expenses -858.26 Thousand - - - - -34.04 Thousand
Cost and Expenses 367.47 Thousand 842.33 Thousand 2.81 Million 2.78 Million 982.64 Thousand 1.7 Million
Operating Income - -842.33 Thousand -2.81 Million -2.78 Million -996.64 Thousand -1.7 Million
Interest Expense 171.39 Thousand 149.84 Thousand 75.71 Thousand 186.06 Thousand 321.18 Thousand 679.12 Thousand
Income Tax Expense - 41.03 Thousand 75.71 Thousand 186.06 Thousand 321.18 Thousand 677.63 Thousand
Earnings before Tax -6.28 Million -256.65 Thousand -3.81 Million -8.26 Million -672.83 Thousand -4.93 Million
Net Income -6.28 Million -256.65 Thousand -3.81 Million -8.26 Million -672.83 Thousand -4.93 Million
Earnings Per Share Basic - -0.00 -0.03 -0.09 -0.02 -0.18
Earnings Per Share Diluted - -0.00 -0.03 -0.09 -0.02 -0.18
Weighted Average Shares Outstanding - 146.39 Million 139.89 Million 93.89 Million 35.88 Million 27.47 Million
Weighted Average Shares Outstanding (Diluted) - 146.39 Million 139.89 Million 93.89 Million 35.88 Million 27.47 Million
Gross Margin 0.44 - - - - -
EBIT Margin -16.53 - - - - -
Profit Margin -17.11 - - - - -
EBITDA -6.07 Million -842.33 Thousand -2.32 Million -2.47 Million -851.62 Thousand -
Earnings Before Tax Margin - - - - - -

Income Statement Charts